Task: Answer the multiple choice question.
Query: Which compound exhibits a 3.436\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. Cc1nc2c(c(N3CCOCC3)n1)OCC(=O)N2
b. O=[N+]([O-])c1ccc(-[n+]2c(-c3ccccc3)cc(-c3ccccc3)cc2-c2ccccc2)cc1.[O-][Cl+3]([O-])([O-])[O-]
Answer: a. Cc1nc2c(c(N3CCOCC3)n1)OCC(=O)N2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc2c(c(N3CCOCC3)n1)OCC(=O)N2
Cc1nc2c(c(N3CCOCC3)n1)OCC(=O)N2
2-methyl-4-morpholin-4-yl-8H-pyrimido[5,4-b][1,4]oxazin-7-one